Navigation Links
Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
Date:4/26/2012

LAKE FOREST, Ill., April 26, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that the company will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Wednesday, May 16, 2012, in Las Vegas.

The presentation is scheduled to begin at 8:40 a.m. Pacific time on Wednesday, May 16, 2012. It will be available to all interested parties through a live audiocast accessible via the investor relations section of Hospira's website at www.hospirainvestor.com. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast.  A replay of the webcast will be available on the Hospira website approximately 24 hours after the live presentation for 30 days after the event.

About Hospira
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Hospira Joins the Generic Pharmaceutical Association
2. Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Months Supply of New Product Immediately and on Track to Ensure Sustainable Supply
3. Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical Program
4. Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 Projections
5. Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012
6. Hospira Reports Third-Quarter 2011 Results
7. Hospira Announces Certain Preliminary Third-Quarter 2011 Results
8. Hospira to Host Conference Call for Third-Quarter 2011 Results
9. Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal Patients
10. Hospira to Host 2011 Investor Day
11. Hospira to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... de 2016  A Proliant Biologicals anuncia, com ... bovina (BSA -- Bovine Serum Albumin ) ... Norte da Nova Zelândia, em Feilding. ... da Proliant nos EUA, localizada em ... dos equipamentos foram feitos de forma a reproduzir ...
(Date:2/11/2016)... , Ill. and INDIANAPOLIS , Feb. ... for many young people, but for those with type ... only do these students juggle class schedules, assignments and ... living with type 1 diabetes. On top of that, ... time. Diabetes Scholars Foundation (Foundation) Lilly ...
(Date:2/11/2016)... , February 11, 2016 ... release of a new research report, titled "Sports Medicine Devices ... Forecast, 2013 - 2019". According to the report, the global ... 4.40% CAGR from 2013 to 2019, growing from a value ... --> --> The global ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... , ... PharmMD CEO Robert Yeager announced today ... contract negotiations, corporate strategy and healthcare data law. Additional responsibilities will include healthcare ... breaches for the Part D Star Rating improvement and Medication Therapy Management firm. ...
(Date:2/11/2016)... NY (PRWEB) , ... February 11, 2016 , ... ... enhanced and updated its hallmark resource, Infusion Therapy Standards of Practice, to include ... in vein illumination with an estimated 85% share of the market, facilitates adherence ...
(Date:2/11/2016)... ... 11, 2016 , ... The annual list showcases the 20 Most Promising SharePoint ... dedication and commitment to the SharePoint ecosystem. A panel of experts and members ... is to recognize and promote technology entrepreneurship. , The survey was made at ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... ergoFET force gauges used in physical therapy, occupational therapy and sports medicine clinics, ... resistance cord exercise and therapy, introduces its new microFET Digital Pinch Gauge. ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... in significantly higher rates of several common cancer screenings, especially among women. Cancer ... outcomes and survival rates. , The study,“What Does Medicaid Expansion Mean for ...
Breaking Medicine News(10 mins):